TECHWIRE 30
(CIX: WRAL30)  1,180.23  up arrow+14.91  (1.28 %)  Updated: 03:50 PM EDT, Mar 30 2015
(NQ: Apple)  126.35  up arrow+3.1  (2.52 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NY: QUINTILES)  68.04  up arrow+0.78  (1.16 %)  Updated: 03:51 PM EDT, Mar 30 2015
(OP: BASF SE)  102.20  up arrow+1.58  (1.57 %)  Updated: 03:42 PM EDT, Mar 30 2015
(NQ: BioCryst)  8.55  up arrow+0.25  (3.01 %)  Updated: 03:50 PM EDT, Mar 30 2015
(NQ: BioDelivery)  10.53  down arrow-3.36  (-24.19 %)  Updated: 03:50 PM EDT, Mar 30 2015
(NQ: CEMP)  34.90  up arrow+2.9  (9.06 %)  Updated: 03:50 PM EDT, Mar 30 2015
(NQ: Cisco Systems)  27.69  up arrow+0.56  (2.05 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NQ: Cree)  35.45  up arrow+0.42  (1.2 %)  Updated: 03:50 PM EDT, Mar 30 2015
(NQ: DARA)  0.72  down arrow-0.07  (-8.54 %)  Updated: 03:50 PM EDT, Mar 30 2015
(NY: EMC CORPORATION)  25.53  up arrow+0.36  (1.43 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NQ: Extreme Networks)  3.15  up arrow+0.07  (2.27 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NQ: FB)  83.26  down arrow-0.04  (-0.05 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NY: GLAXOSMITHKLINE)  47.20  up arrow+0.18  (0.37 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NQ: GOOG)  552.25  up arrow+3.91  (0.71 %)  Updated: 03:50 PM EDT, Mar 30 2015
(NY: IBM)  162.64  up arrow+2.24  (1.4 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NY: LH)  127.20  up arrow+0.05  (0.04 %)  Updated: 03:50 PM EDT, Mar 30 2015
(OP: Lenovo Group)  28.79  up arrow+0.22  (0.77 %)  Updated: 03:47 PM EDT, Mar 30 2015
(NY: MRK)  58.38  up arrow+0.63  (1.09 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NQ: Microsoft Corp)  40.95  down arrow-0.03  (-0.06 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NQ: NTAP)  35.38  up arrow+0.28  (0.8 %)  Updated: 03:50 PM EDT, Mar 30 2015
(NY: NOVARTIS AG)  101.40  up arrow+1  (1 %)  Updated: 03:51 PM EDT, Mar 30 2015
(OP: Novozymes A/S)  46.73  up arrow+0.79  (1.71 %)  Updated: 03:47 PM EDT, Mar 30 2015
(NY: PFIZER)  35.11  up arrow+0.58  (1.67 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NQ: Pozen)  7.67  down arrow-0.01  (-0.13 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NY: RED HAT)  76.68  up arrow+0.16  (0.21 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NQ: BBRY)  8.82  down arrow-0.65  (-6.82 %)  Updated: 03:51 PM EDT, Mar 30 2015
(NQ: Salix)  172.74  up arrow+0.14  (0.08 %)  Updated: 03:50 PM EDT, Mar 30 2015
(NQ: SQI)  17.34  up arrow+0.22  (1.29 %)  Updated: 03:50 PM EDT, Mar 30 2015

Posts tagged “Salix”

August 25, 2005

Premium Lock Drug Manufacturer Salix Suggests Better Treatment for Relief of Cancer Side Effects

Study suggests relief is in site for patients receiving medical treatment for prostate cancer. Drug may have a new purpose.

Tags: Salix
August 9, 2005

Premium Lock Earnings: Salix Reports Surge in Profits; Inspire Revenues Climb

Salix produces 13-cent a share profit as sales far outpace expenses; Inspire cuts losses as co-marketed drug sales increase; Icagen reports a loss but notes progress on drugs.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith